MX2022006947A - Composicion antimicrobiana. - Google Patents

Composicion antimicrobiana.

Info

Publication number
MX2022006947A
MX2022006947A MX2022006947A MX2022006947A MX2022006947A MX 2022006947 A MX2022006947 A MX 2022006947A MX 2022006947 A MX2022006947 A MX 2022006947A MX 2022006947 A MX2022006947 A MX 2022006947A MX 2022006947 A MX2022006947 A MX 2022006947A
Authority
MX
Mexico
Prior art keywords
hydrogen peroxide
composition
oxidoreductase
antimicrobial composition
sugar
Prior art date
Application number
MX2022006947A
Other languages
English (en)
Inventor
John Reginald Barrett
James Joseph Brennan
Thomas Patrick Patton
Original Assignee
Atlantic Technological Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlantic Technological Univ filed Critical Atlantic Technological Univ
Publication of MX2022006947A publication Critical patent/MX2022006947A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/08—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición que comprende una fuente de peróxido de hidrógeno y al menos un haluro metálico. La fuente de peróxido de hidrógeno comprende peróxido de hidrógeno y un medio para generar peróxido de hidrógeno. El medio para producir peróxido de hidrógeno comprende al menos una oxidorreductasa y al menos un sustrato de oxidorreductasa. El sustrato de oxidorreductasa comprende al menos un azúcar, dicho azúcar se ubica dentro de la composición. La composición se mantiene en condiciones que inactivan los componentes hasta que se rehidratan.
MX2022006947A 2019-12-09 2020-12-09 Composicion antimicrobiana. MX2022006947A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1918021.5A GB2589863A (en) 2019-12-09 2019-12-09 Antimicrobial composition
PCT/EP2020/085376 WO2021116228A1 (en) 2019-12-09 2020-12-09 Antimicrobial composition

Publications (1)

Publication Number Publication Date
MX2022006947A true MX2022006947A (es) 2023-03-15

Family

ID=69172144

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006947A MX2022006947A (es) 2019-12-09 2020-12-09 Composicion antimicrobiana.

Country Status (11)

Country Link
US (1) US20230022880A1 (es)
EP (1) EP4072294A1 (es)
JP (1) JP2023505707A (es)
CN (1) CN115279187A (es)
AU (1) AU2020401747A1 (es)
CA (1) CA3161279A1 (es)
GB (1) GB2589863A (es)
IL (1) IL293757A (es)
MX (1) MX2022006947A (es)
WO (1) WO2021116228A1 (es)
ZA (1) ZA202206663B (es)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617190A (en) * 1984-08-27 1986-10-14 Laclede Professional Products, Inc. Enzymatic powder milk
WO1992014484A1 (en) * 1991-02-21 1992-09-03 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
BR9811156A (pt) * 1997-08-14 2000-07-25 Novo Nordisk As Composição enzimática antimicrobiana, uso da mesma, e, processos de inibição de microorganismos presentes em roupa suja, de conservação de um produto cosmético, e de limpeza, desinfecção ou inibição de crescimento microbiano em uma superfìcie dura
AU6558100A (en) * 1999-08-13 2001-03-13 Novozymes A/S Enzymatic method for killing or inhibiting microbial cells at high ph
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
PE20030729A1 (es) * 2002-01-18 2003-10-21 Novartis Ag Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas
PT1693073E (pt) 2002-04-24 2014-09-18 Archimed Llp Pensos para feridas incluindo hidrogéis hidratados e enzimas
PT1893187E (pt) * 2005-06-13 2009-02-24 Flen Pharma N V Dispositivo para próprio aumentar o grau de segurança de portas ou de elementos semelhantes a portas contra tentativas de arrombamento
US20060289354A1 (en) * 2005-06-15 2006-12-28 Buckman Laboratories International, Inc. Method and composition to control the growth of microorganisms in aqueous systems and on substrates
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
IE20090232A1 (en) * 2008-03-26 2009-10-28 Inst Of Technology Sligo An antimicrobial composition
EP2510944A1 (en) * 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections
US20150150908A1 (en) * 2013-12-03 2015-06-04 Team Unlimited, LLC Compositions and methods for treating skin wounds
US9814234B2 (en) * 2014-01-14 2017-11-14 Exoxemis, Inc. Bioactive heme-haloperoxidase compositions and methods of their use
GB2547402B (en) * 2014-11-24 2018-03-28 Matoke Holdings Ltd Prevention and treatment of microbial infections
RU2586292C1 (ru) * 2015-03-03 2016-06-10 Александр Ливиевич Ураков Лимфозаменитель для локального сохранения жизнеспособности органов и тканей при гипоксии и ишемии
EP3541437A1 (en) * 2016-11-15 2019-09-25 Matoke Holdings Limited Antimicrobial compositions and formulations

Also Published As

Publication number Publication date
IL293757A (en) 2022-08-01
US20230022880A1 (en) 2023-01-26
GB2589863A (en) 2021-06-16
WO2021116228A1 (en) 2021-06-17
CA3161279A1 (en) 2021-06-17
AU2020401747A1 (en) 2022-07-07
GB201918021D0 (en) 2020-01-22
EP4072294A1 (en) 2022-10-19
CN115279187A (zh) 2022-11-01
JP2023505707A (ja) 2023-02-10
ZA202206663B (en) 2023-07-26

Similar Documents

Publication Publication Date Title
PH12020551923A1 (en) Methods and compositions for treating cancer
MX2023005160A (es) Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma.
AU2017332777A8 (en) Dynamic function row customization
EP3959981A3 (en) Fungicidal combinations
MX2021006564A (es) Sistemas activos dinamicos acromosomicos.
WO2018013166A8 (en) DETERMINING OPTIMUM DELIVERY TIMES FOR ELECTRONIC MESSAGES
MX2021012973A (es) Sustituto de huevo y composiciones que comprenden el sustituto de huevo y metodos para producir el mismo.
MX2018010266A (es) Métodos, dispositivos y sistemas para procesamiento de composiciones carbonosas.
SG11201811130YA (en) Film formation method
MX2021000066A (es) Métodos y composiciones para la preparacion de tagatosa a partir de fructosa.
MX2020012754A (es) Procesos para mejorar el crecimiento y la productividad de la levadura.
MX2022007841A (es) Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos.
MX2022008099A (es) Tratamiento para el cancer con inhibidores de cdk12/13.
WO2020214220A3 (en) Cannabinoid systems and methods: water-solubility, targeting, and augmentation
MX2021003159A (es) Microemulsiones que contienen antioxidantes.
MX2022006947A (es) Composicion antimicrobiana.
MX2021010381A (es) Cierre de aparato iluminado.
EP4034685A4 (en) DIRECT REDUCTION CARBIDED METAL PRODUCTION METHOD AND DEVICE
WO2020086954A3 (en) Treatments for charcot-marie-tooth disease
JOP20210107A1 (ar) مضمنات التعبير عن foxp3
SG10201806014TA (en) Feedback canceller and hearing aid
WO2019038589A3 (de) Druckplatte
MX2019009200A (es) Composiciones y métodos para inhibir el reticulón 4.
SA518391213B1 (ar) -l طــريـقـة لإنـــتـاج مـــيــثـيونــيــن
MX2021010229A (es) Mogrosidos novedosos y usos de los mismos.